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Zika Virus Overview
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Zika Virus
• Single stranded RNA Virus
• Genus Flavivirus, Family Flaviviridae
• Closely related to dengue, yellow fever, Japanese encephalitis and 
West Nile viruses
• Transmitted to humans primarily by Aedes (Stegomyia) species 
mosquitoes
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Zika Virus Vectors:
Aedes Mosquitoes
Aedes aegypti mosquito
Aedes albopictus mosquito
§ Aedes species mosquitoes
• Ae aegypti more efficient vectors for humans
• Ae albopictus  
§ Also transmit dengue and chikungunya viruses
§ Lay eggs in domestic water-holding containers
§ Live indoors and outdoors
§ Aggressive daytime biters; can also bite at night
§ Prefer to bite people
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Other Modes of Transmission 
The Subcommittee on Arbovirus Laboratory Safety of the American Committee on Arthropod-Borne Viruses. Laboratory safety for 
arboviruses and certain other viruses of vertebrates. Am J Trop Med Hyg 1980;29:1359–81.
European Centre for Disease Prevention and Control. Rapid risk assessment: Zika virus epidemic in the Americas: potential association with 
microcephaly and Guillain-Barre syndrome. Stockholm, Sweden: European Centre for Disease Prevention and Control; 2015.
§ Maternal-fetal 
•Intrauterine
•P inatal
§  Sexual 
§ Laboratory 
exposure 
§ Theoretical
•Blood 
transfusion
•Organ or 
tissue 
transplantatio
n
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Zika Virus and Sexual Transmission
• Zika virus can be spread by a man to his sex partners
• Pregnant women with male partners who have or are at risk of 
Zika virus infection should abstain or use condoms for the 
duration of pregnancy
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Zika Virus Disease Symptoms
• Most common symptoms include:
• Rash
• Fever
• Joint pain
• Conjunctivitis (red eyes) 
• Other symptoms include:
• Muscle pain
• Headache
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Zika Virus Clinical Disease Course and Outcomes
• Clinical illness usually mild
• Symptoms last several days to a week 
• Severe disease requiring hospitalization uncommon
• Fatalities are rare
• Guillain-Barré syndrome reported in patients following 
suspected Zika virus infection 
• Relationship to Zika virus infection under investigation
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Complications of Zika Virus 
• Guillain-Barré syndrome (GBS) has been reported 
after Zika virus infection, but causal link has not been established
• Unclear how many people have had GBS after Zika virus infection
• Brazil: 6 patients aged 2-57 years with neurologic syndromes (GBS and Acute 
Disseminated Encephalomyelitis) after Zika infection
• French Polynesia: 38 cases of GBS, none among children
• Overall, GBS incidence appears to increase with increasing age
European Centre for Disease Prevention and Control. Rapid risk assessment: Zika virus infection outbreak, French Polynesia. 14 February 2014. Stockholm: ECDC; 2014.
Minstério de Saúde. Protocolo de vigilância e resposta à ocorrência de microcefalia relacionada à infecção pelo vírus Zika 2015. 
http://portalsaude.saude.gov.br/images/pdf/2015/dezembro/09/Microcefalia---Protocolo-de-vigil--ncia-e-resposta---vers--o-1----09dez2015-8h.pdf
Sejvar J, Baughman A, Wise M, Morgan O. Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology. 
2011;36(2):123-33 10
Distinguishing Zika from Dengue and 
Chikungunya
• Dengue and chikungunya viruses transmitted by same mosquitoes with 
similar ecology
• Dengue and chikungunya can circulate in same area and rarely cause co-
infections
• Diseases have similar clinical features
• Important to rule out dengue, as proper clinical management can 
improve outcome*
*WHO dengue clinical management guidelines:
http://whqlibdoc.who.int/publications/2009/9789241547871_eng.pdf 11
Zika Virus Epidemiology 
• First isolated from a monkey in Uganda in 1947
• Prior to 2007, only sporadic human disease cases reported 
from Africa and southeast Asia
• In 2007, first outbreak reported on Yap Island, Federated 
States of Micronesia
• In 2013–2014, >28,000 suspected cases reported from 
French Polynesia*
*http://ecdc.europa.eu/en/publications/Publications/Zika-virus-French-Polynesia-rapid-risk-assessment.pdf12
Zika Virus in Yap Island Outbreak
• Infection rate: 73% (95%CI 68–77%)
• Symptomatic attack rate among infected: 18% (95%CI 10–27%)
• All age groups affected
• Adults more likely to present for medical care
• No severe disease, hospitalizations, or deaths
Note: Rates based on serosurvey on Yap Island, 2007 (population 7,391)
Duffy M. NEJM 2009
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Zika Virus in the Americas 
• In May 2015, the first locally-acquired 
cases in the Americas were reported 
in Brazil
• Currently, outbreaks are occurring in 
many countries or territories in the 
Americas, including the 
Commonwealth of Puerto Rico, the 
U.S. Virgin Islands, and American 
Samoa
• Spread to other countries likely
*Last updated March 
22nd 14
Zika Virus in the United States 
• Local vector-borne transmission of Zika virus has not been reported in 
the continental United States
• With current outbreak in the Americas, cases among U.S. travelers will 
likely increase
• Imported cases may result in virus introduction and local transmission in 
some areas of U.S.
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Zika Virus in the United States, 30 March 2016
• US States
• 312 travel-associated cases
• 27 pregnant women
• 6 sexually transmitted
• 0 locally-acquired vector-borne cases
• US Territories
• 3 travel-associated cases
• 349 locally acquired cases
• 37 pregnant women 16
Diagnostic Testing for Zika Virus
• Reverse transcriptase-polymerase chain reaction (RT-PCR) for viral RNA in 
serum collected ≤7 days after illness onset
• Serology for IgM and neutralizing antibodies in serum collected ≥4 days 
after illness onset
• Immunohistochemical (IHC) staining for viral antigens or RT-PCR on fixed 
tissues
• More information about laboratory testing can be found at: http://
www.cdc.gov/zika/state-labs/index.html
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Serology Cross-Reactions with Other 
Flaviviruses 
• Zika virus serology (IgM) can be positive due to antibodies against related 
flaviviruses (e.g., dengue and yellow fever viruses)
• Neutralizing antibody testing may discriminate between cross-reacting 
antibodies in primary flavivirus infections
• Difficult to distinguish infecting virus in people previously infected with 
or vaccinated against a related flavivirus
• Healthcare providers should work with state, territorial, and local health 
departments to ensure test results are interpreted correctly
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Laboratories for Diagnostic Testing 
• No commercially-available diagnostic tests
• Testing performed at CDC and a few state health departments 
• CDC is working to expand laboratory diagnostic testing in states through 
the Laboratory Response Network (LRN)
• Healthcare providers should contact their state or territorial health 
department to facilitate diagnostic testing
Initial Assessment and Treatment 
• No specific antiviral therapy
• Treatment is supportive (i.e., rest, fluids, analgesics, antipyretics) 
• Suspected Zika virus infections should be evaluated and managed for 
possible dengue or chikungunya virus infections
• Aspirin and other NSAIDs should be avoided until dengue can be ruled 
out to reduce the risk of hemorrhage 
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Reporting Zika Virus Disease Cases
• Zika virus disease is a nationally notifiable disease
• Healthcare providers are encouraged to report cases with laboratory evidence of 
Zika infection to their state, tribal, local, or territorial health department
• Health departments are requested to report cases with laboratory 
evidence of Zika infection to CDC
• Timely reporting allows health departments to assess and reduce the risk 
of local transmission or mitigate further spread
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Zika Virus Preventive Measures in Puerto Rico
• No vaccine or medication to prevent infection or disease
• Primary prevention measure is to reduce mosquito exposure
• Protect infected people from mosquito exposure during first week of 
illness to prevent further transmission
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Protecting Pregnant Women: Zika Prevention 
Kits (ZPKs)
• What’s in a ZPK- Wave 1 for Puerto Rico?
• Educational materials in English and Spanish
• EPA-registered insect repellent
• Condoms to reduce possible sexual transmission of Zika
• Thermometer 
• Treatment tabs for preventing 
   mosquitoes from breeding in standing 
   water
• Bed net
23
Zika Virus in Pregnant Women
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Zika Virus in Pregnancy
• Limited information is available
• Existing data show:
• No evidence of increased susceptibility
• No evidence of more severe disease compared with non-
pregnant people
Centers for Disease Control and Prevention, CDC Health Advisory:  Recognizing, Managing, and Reporting Zika Virus Infections in Travelers Returning from Central America, South America, the 
Caribbean and Mexico, 2016.
Besnard, M., et al., Evidence of Perinatal Transmission of Zika Virus, French Polynesia, December 2013 and February 2014. Euro Surveill, 2014. 19(14): p. 1-5.
Oliveira Melo, A., et al., Zika Virus Intrauterine Infection Causes Fetal Brain Abnormality and Microcephaly: Tip of the Iceberg? Ultrasound in Obstetrics & Gynecology, 2016. 47(1): p. 6-7.25
What is Microcephaly?
• Clinical finding of a small head when compared to infants 
of same sex and age
• Reliable assessment of intracranial brain volume 
• Often leads to cognitive and/or neurologic issues
• Mechanisms
• Primary due to abnormal development (often with a genetic 
etiology) 
• Secondary due to destruction of normally-forming brain tissue 
(by infection, vascular disruption)
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Microcephaly Surveillance and Monitoring
• Difficult birth defect to monitor because of inconsistent definition and 
use of terminology
• Typically, in the US, below the third percentile on a standard growth 
chart identifies infants with microcephaly. However, standards can vary 
• CDC 
guidelines for evaluation and testing of infants with possible congenital Zika virus infection
 provide a standard case definition for microcephaly  
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Microcephaly and Zika
What we know
• Small number of positive test results for 
Zika virus infection in infants with 
microcephaly
• Microcephaly pattern consistent with Fetal 
Brain Disruption Sequence 
• Based on photos/scans of a small number 
of affected infants from Brazil
• Retrospective investigation in French 
Polynesia outbreak in 2013-2014
• Infants with other intrauterine infections 
such as cytomegalovirus
What we don’t know
• Causal relation between Zika virus and 
microcephaly or other adverse pregnancy 
outcomes
• Full spectrum of phenotypes in affected 
infants
• Impact of timing of infection during 
pregnancy
• Impact of severity of maternal infection
• Magnitude of the possible risk of 
microcephaly and other adverse pregnancy 
outcomes
Pregnancy Outcomes and Zika Virus
• A range of other problems have been detected among fetuses and infants 
infected with Zika virus before birth including: 
• Absent or poorly developed brain structure
• Defects of the eye
• Impaired growth
• Although Zika has been linked with birth defects and other problems in 
infants, there is more to learn
• Researchers are collecting data to better understand the impact of Zika on 
mothers and their children
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CDC Recommendations:  
Pregnant Women Considering Travel 
• Pregnant women in any trimester should consider postponing travel to 
areas where Zika is present
• Pregnant women who do travel to one of these areas should talk to their 
healthcare provider and strictly follow steps to avoid mosquito bites 
during the trip
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Evaluating Pregnant Travelers
• Recommendations
• Ask pregnant women about travel history. 
• If history of travel to an area with ongoing Zika virus transmission during 
pregnancy, evaluate for symptoms of and test for Zika virus infection.
• Pregnant women with male partners who have Zika virus infection or potential 
Zika virus exposure should use condoms or abstain from sexual activity for the 
duration of pregnancy.
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CDC Recommendations: 
Testing for Asymptomatic Pregnant Women with 
Possible Zika Virus Exposure
• Serologic (IgM) testing can be offered to asymptomatic pregnant women
• Negative IgM result could suggest a recent infection did not occur and 
obviate need for serial ultrasounds
• Information about performance of testing of asymptomatic persons 
limited
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Zika Virus Disease Prevention:
Pregnant Women
• CDC recommends taking the following steps to prevent mosquito bites: 
• Use EPA-registered insect repellents, including DEET and permethrin 
• Wear long-sleeved shirts and pants to cover exposed skin
• Stay and sleep in screened-in or air-conditioned rooms
• Wear permethrin-treated clothes
• Practice mosquito prevention strategies indoors and outdoors throughout the 
entire day
• Pregnant women with male partners who have Zika virus infection 
should take the following measures to prevent sexual transmission:
• Use condoms the right way every time or
• Abstain from sexual activity for the duration of pregnancy
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Areas With Ongoing Zika Virus Transmission:
Evaluating Pregnant Residents
• Healthcare providers should
• Evaluate for symptoms of Zika virus infection
• Perform appropriate testing according to CDC’s guidelines
• Local health officials should determine when to implement testing of 
asymptomatic pregnant women based on levels of Zika transmission and 
laboratory capaticy
• Recommendations 
• Offer serologic testing at
• Initiation of prenatal care 
• Follow up mid-2nd trimester
• Routine ultrasound screening recommended for all pregnant women at 18–20 weeks 
of gestation 34
Centers for Disease Control and Prevention
CDC’s updated pregnancy guidelines
Acute Zika Virus Disease in 
Infants and Children
36
Clinical Manifestations of Zika Virus in Children 
• Most children asymptomatic or have mild illness
• Zika virus outbreak in Yap Island, Micronesia, 2007
• Illness reported in persons 1-76 years of age
• Most common signs and symptoms: rash (macular or papular), fever, arthralgia, 
conjunctivitis 
• Children 0-19 years had lower attack rates than adults 20-59 years
• Among 8 travel-related cases of Zika virus disease in children in US
• All had rash and at least one additional manifestation (fever, arthralgia, and 
nonpurulent conjunctivitis)
Duffy MR, Chen TH, Hancock WT, Powers AM, Kool JL, Lanciotti RS, et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. The New England 
journal of medicine. 2009 Jun 11;360(24):2536-43
CDC unpublished data, 2016 37
Zika Virus Laboratory Testing of Infants
• Recommended for 
1. Infants with microcephaly or intracranial calcifications born 
to women who resided in an area with Zika virus 
transmission while pregnant 
2. Infants born to mothers with positive or inconclusive test 
results for Zika virus infection 
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Infants without microcephaly or intracranial calcifications 
whose mothers traveled to or resided in areas with 
ongoing Zika transmission during pregnancy but were not 
tested
• If infant has normal head circumference, prenatal ultrasounds, postnatal 
ultrasounds (if performed), physical examination  routine care
• Use clinical judgment if an infant has abnormalities other than 
microcephaly or intracranial calcifications
• Consider testing mother before infant
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Centers for Disease Control and Prevention
CDC’s updated pediatric guidance
CDC Activities and Plans
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CDC Response to Zika
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CDC Activities and Plans
• Very little is known about the risks of Zika virus infection during pregnancy 
• Increased understanding of the impact of Zika virus infection on pregnant women 
and their infants is needed
• To learn more about the impact of Zika virus infection during pregnancy, CDC is 
collaborating with state, tribal, local, and territorial health departments to collect 
information about women infected with Zika virus during pregnancy and their infants
• The information collected will:
• Direct public health efforts intended to mitigate the impact of Zika virus infection 
• Guide recommendations for the monitoring and treatment of women affected by 
Zika during pregnancy
Zika Pregnancy Surveillance 
• In collaboration with state and territorial health departments, CDC has established 
two surveillance systems for pregnant women with Zika virus infection 
• US Zika Pregnancy Registry
• 50 U.S. States & Washington, DC
• Zika Active Pregnancy Surveillance System (ZAPSS)
• Puerto Rico
• Data collected via medical record abstraction 
• Surveillance systems will facilitate public health response for pregnant women with 
Zika virus infection
Clinical Inquiries Hotline 
• Call the CDC Emergency Operations Center Watch Desk at 770-488-7100 
and ask for the Zika Pregnancy Hotline 
• Email ZikaMCH@cdc.gov.
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Summary
• Zika virus continues to circulate and cause locally-transmitted disease in 
the Americas
• Consider the possibility of Zika virus infection in travelers with acute 
fever, rash, arthralgia, or conjunctivitis within 2 weeks after return
• A substantial increase in rates of congenital microcephaly have been 
reported in Brazil
• Research is underway to characterize the relationship between Zika and 
congenital microcephaly
• Pregnant women in any trimester should consider postponing travel to 
areas of Zika virus transmission
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www.cdc.gov/zika 
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Additional resources
• CDC Zika virus information: http://www.cdc.gov/zika/ 
• PAHO Zika virus pages:  http://
www.paho.org/hq/index.php?option=com_topics&view=article&id=427&Itemid=41484&lang=en
 
• Zika virus information for clinicians: http://
www.cdc.gov/zika/hc-providers/index.html   
• Zika virus information for travelers and travel health providers: http://
wwwnc.cdc.gov/travel/yellowbook/2016/infectious-diseases-related-to-travel/zika
 
• Travel notices: http://wwwnc.cdc.gov/travel/notices 
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For more information, contact CDC
1-800-CDC-INFO (232-4636)
TTY:  1-888-232-6348    www.cdc.gov
The findings and conclusions in this report are those of the authors and do not necessarily represent the 
official position of the Centers for Disease Control and Prevention.
Thanks to our many collaborators and partners!
Back up slides
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Pregnancy Outcomes and Zika Virus
• Pregnant woman residing in Brazil
• Symptoms of Zika virus disease at 10 weeks
• Ultrasound findings
• 22 weeks: Fetal mild hypoplasia of cerebellar vermis and head circumference <10th percentile
• 25 weeks: Fetal microcephaly (head circumference <3rd percentile) with severe hypoplasia of 
cerebellar vermis, enlargement of posterior fossa, normal brain parenchyma
• Testing
• 28 weeks: Amniotic fluid positive for Zika virus RNA; serum and urine negative by Zika RT-PCR
• Delivery
• Infant born with severe ventriculomegaly, microphthalmia, cataracts and severe arthrogryposis
Calvet Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study. Lancet Infect Dis 2016. Epub February 17, 2016.52
Pregnancy Outcomes and Zika Virus
• Pregnant woman residing in Brazil
• Symptoms of Zika virus disease at 18 weeks
• Ultrasound findings
• 16 weeks: Normal
• 21 weeks: Fetal microcephaly with moderate ventriculomegaly and partial 
agenesis of the cerebellar vermis
• 27 weeks: Fetal microcephaly with ventricular dilation, asymmetry of 
hemispheres, hypoplastic cerebellum and absence of cerebellar vermis
• 40 weeks: Fetal microcephaly with calcifications
• Testing
• 28 weeks: Amniotic fluid positive for Zika virus RNA, serum and urine negative by Zika RT-
PCR
• Delivery at 40 weeks
• Infant born with head circumference <1st percentile
Calvet Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study. Lancet Infect Dis 2016. Epub February 17, 2016.53
Pregnancy Outcomes and Zika Virus
• Two pregnant women in Brazil had clinical signs of Zika during first 
trimester
• Infants born with microcephaly at 36 and 38 weeks gestation
• Died within 20 hours of birth
• Zika virus RNA detected in brain tissue of both infants
• Significant histopathologic changes in the brain
• Parenchymal calcification and necrosis
Martines RB, Bhatnagar J, Keating MK, et al. Notes from the Field: Evidence of Zika Virus Infection in Brain and Placental Tissues from Two Congenitally Infected 
Newborns and Two Fetal Losses — Brazil, 2015. MMWR Morb Mortal Wkly Rep 2016;65(Early Release):1–2 . 54
Pregnancy Outcomes and Zika Virus
• Two additional women in Brazil had clinical signs of Zika during the first 
trimester 
• Two fetal losses at 11 & 13 weeks gestation
• Zika virus RNA detected in products of conception
• Zika viral antigen detected by immunohistochemistry in one case
• Histopathologic changes in one case 
• Calcification and fibrosis in the chorionic villi
Martines RB, Bhatnagar J, Keating MK, et al. Notes from the Field: Evidence of Zika Virus Infection in Brain and Placental Tissues from Two Congenitally Infected 
Newborns and Two Fetal Losses — Brazil, 2015. MMWR Morb Mortal Wkly Rep 2016;65(Early Release):1–2 . 55
Pregnancy Outcomes and Zika Virus
• Pregnant woman residing in Brazil from preconception until 29 weeks of gestation
• Symptoms of Zika virus disease at 13 weeks
• Ultrasound findings
• 14 & 20 weeks: normal fetal growth & anatomy
• 29 weeks: evidence of fetal anomalies
• 32 weeks: intrauterine growth restriction, microcephaly, and other brain 
abnormalities
• Termination at 32 weeks 
• Brain weight 4 SD below normal
• Zika virus RNA detected in fetal brain tissue
• Almost complete agyria and internal hydrocephalus of lateral ventricles
Mlakar J, Korva M, Tul N, et al. Zika Virus Associated with Microcephaly. NEJM 2016 Feb 10. 56
Women of Reproductive Age Residing in Areas of Ongoing 
Zika Virus Transmission
• For women who do not desire pregnancy, provide counseling on
– Correct and consistent use of effective contraception
– Condoms to reduce risk of contracting sexually transmitted infections
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Recommended Zika Virus Testing for Infants*
• Recommended tests
• Zika virus RNA (RT-PCR), IgM, and neutralizing antibodies
• Dengue virus IgM and neutralizing antibodies
• Clinical specimens
• Serum (umbilical cord or direct, within 2 days of birth if possible)
• Cerebrospinal fluid, if obtained for other studies
• Consider histopathologic evaluation (placenta and umbilical 
cord)
• Zika virus immunohistochemical staining (fixed tissue)
• Zika virus RT-PCR (fixed and frozen tissue)
• Additionally, if not already performed, test mother’s serum
• Zika virus IgM and neutralizing antibodies
• Dengue virus IgM and neutralizing antibodies
*When indicated, including: 1) infants with microcephaly or intracranial calcifications born to women potentially exposed to 
Zika virus during pregnancy, or 2) infants born to mothers with positive or inconclusive test results for Zika virus infection. 
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Evaluation and Testing for All Infants with 
Possible Congenital Zika Virus Infection
For all infants with possible congenital Zika virus infection, perform the following:
• Thorough physical examination, including careful measurement of the head 
circumference, length, weight, and assessment of gestational age*
• Cranial ultrasound, unless prenatal ultrasound results from third trimester demonstrated 
no abnormalities of the brain
• Further evaluation
• neurologic abnormalities, dysmorphic features, splenomegaly, hepatomegaly, and rash or other 
skin lesions* 
• hearing by evoked otoacoustic emissions testing or auditory brainstem response testing, either 
before discharge from the hospital or within 1 month after birth* 
• eye exam to include visualization of the retina, optic nerve, and macula either before discharge 
from the hospital or within 1 month after birth* 
• Other evaluations specific to the infant’s clinical presentation
          *If any abnormalities are noted, consultation with the appropriate specialist is recommended.
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Additional Evaluation for Infants with 
Microcephaly or Intracranial Calcifications
• For infants with microcephaly, consultations are recommended with
• A clinical geneticist or dysmorphologist
• A pediatric neurologist to determine appropriate brain imaging and additional evaluation (e.g., 
US, CT scan, MRI, and/or EEG)
• A pediatric infectious disease specialist should be considered after testing for other congenital 
infections such as syphilis, toxoplasmosis, rubella, cytomegalovirus, lymphocytic 
choriomeningitis virus, and herpes simplex viruses
• Further testing includes
• Complete blood count, platelet count, and liver function tests including alanine 
aminotransferase, aspartate aminotransferase, and bilirubin
• Consideration of genetic and other teratogenic causes based on additional congenital 
anomalies that are identified through clinical examination and imaging studies
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Recommended Long-Term Follow-up of Infants 
with Possible Congenital Zika Virus Infection
• Report case to state, territorial, or local health department and monitor for additional 
guidance as it released
• Conduct additional hearing screen at age 6 months, plus any appropriate follow-up of 
hearing abnormalities detected through newborn hearing screening
• Carefully evaluate head circumference and developmental characteristics and 
milestones throughout the first year of life
• Use of appropriate consultations with medical specialists (e.g., pediatric neurology, 
developmental and behavioral pediatrics, physical and speech therapy)
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Recommended Testing for Acute Zika Virus 
Disease 
• Test serum and, if obtained for other reasons, cerebrospinal fluid
• If symptoms present for <7 days
• Zika virus RNA by RT-PCR 
• If Zika virus RNA is not detected and symptoms have been present for ≥4 days
• Zika and dengue virus IgM and neutralizing antibodies
• More information about laboratory testing can be found at: 
http://www.cdc.gov/zika/state-labs/index.html
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Laboratory Evidence of Zika Virus Infection
• Positive test results
• In any clinical sample
• Zika virus by culture, RNA by RT-PCR, or antigen 
• Zika virus IgM with confirmatory neutralizing antibodies ≥ 4-fold higher than dengue virus 
neutralizing antibodies
• Inconclusive result
• Zika virus neutralizing antibodies < 4 fold higher than dengue
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Clinical Management
• No specific antiviral treatment
• Supportive care
• Avoid nonsteroidal anti-inflammatory drugs (NSAIDs) until dengue virus 
ruled out and in children <6 months 
• Avoid aspirin in children with suspected viral infection due to the 
association with Reye’s syndrome
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Guidelines for Breastfeeding for Mothers with Zika Virus 
Infection and Living in Areas with Zika virus
• Zika virus RNA has been identified in breast milk
• Zika virus has not been cultured from breast milk
• No cases of Zika transmission associated with breastfeeding have been 
reported
• Mothers are encouraged to breastfeed their infants
• Current evidence: benefits of breastfeeding outweigh theoretical risks
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Prevention of Zika Virus in Infants and Children  
• Mosquito prevention
• Air conditioning  or window and door screens when indoors
• Long-sleeves and long pants
• Use permethrin-treated clothing and gear
• When use as directed on the product label, most EPA*-registered insect 
repellants can be used in children ≥ 2 months
• Oil of lemon eucalyptus should not be used in children < 3 years old
• Mosquito netting for carriers, strollers, or cribs for infants
*EPA= Environmental Protection Agency
Nasci, RS et al. Protection against Mosquitoes, Ticks, & Other Arthropods in Chapter 2: The Pre-Travel Consultation: Counseling & Advice for Travelers
http://wwwnc.cdc.gov/travel/yellowbook/2016/the-pre-travel-consultation/protection-against-mosquitoes-ticks-other-arthropods
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Prevention of Zika Virus Infection in Infants and 
Children
• Healthcare providers should educate 
parents and caregivers about 
mosquito bite prevention in infants 
and children if they are traveling to or 
residing in areas affected by Zika virus
• Parents should protect infants and 
children with Zika virus from 
mosquito bites for at least one week 
to decrease risk of transmission to 
others
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